Affiliation:
1. Curtin University, Australia
Abstract
The pharmaceutical industry is one of the most innovative and research-intensive industries in the world. For example, five out of the top global Research and Development (R&D) companies were pharmaceutical companies. However, the industry is lagging behind other industries in adopting Business-to-Business (B2B) and supply chain technologies. With supply chain costs constituting around 25-40% of an organization's operating expenses, it is imperative for senior pharmaceutical executives to minimize this cost. Hence, the main objective of this chapter is to identify key B2B e-commerce management, evaluation, and benefits realization factors and challenges within the Australian pharmaceutical supply chain. The results of this study suggest that pharmaceutical companies not only need to carefully examine their B2B investment management and evaluation practices but also must invest in using appropriate evaluation methodologies for identifying and managing benefits, risks, and costs associated with their investments in B2B and supply chains.
Reference136 articles.
1. Understanding the influence of user participation and involvement on system success–a systematic mapping study.;U.Abelein;Empirical Software Engineering,2013
2. ABPI. (2012). Global pharmaceutical industry and market. The Association of the British Pharmaceutical Industry (ABPI). Retrieved from http://www.abpi.org.uk/industry-info/knowledge-hub/global-industry/Pages/industry-market-.aspx
3. Developing lean and agile health care supply chains. Supply Chain Management;H.Aronsson;International Journal (Toronto, Ont.),2011
4. RFID, EPC and B2B convergence towards an item-level traceability in the pharmaceutical supply chain
5. An empirical investigation of net-enabled business value;A.Barua;Management Information Systems Quarterly,2004